11/06/2019 16:45:00

Klépierre: DISCLOSURE OF TRADING IN OWN SHARES FROM JUNE 07, 2019 TO JUNE 10, 2019

RELEASE

DISCLOSURE OF TRADING IN OWN SHARES FROM JUNE 07, 2019 TO JUNE 10, 2019

Paris – June 11, 2019

As announced in a press release dated February 06, 2019, Klépierre mandated an investment services provider to repurchase its own shares. The following table sums up the buyback transactions carried out by said provider between June 07 and June 10, 2019:

Name of issuerIdentification code of issuer

(Legal Entity Identifier)

Transaction

date

Identification code of financial instrumentMarket

(MIC Code)

Aggregated daily volume

(in number of shares)

Daily weighted average price of the purchased shares *
Klépierre

Klépierre

Klépierre

Klépierre

Klépierre

969500PB4U31KEFHZ621

969500PB4U31KEFHZ621

969500PB4U31KEFHZ621

969500PB4U31KEFHZ621

969500PB4U31KEFHZ621

07/06/2019

07/06/2019

10/06/2019

10/06/2019

10/06/2019

FR0000121964

FR0000121964

FR0000121964

FR0000121964

FR0000121964

XPAR

CHIX

XPAR

CHIX

BATE

95,149

27,851

93,781

13,303

12,916

29.13

29.13

29.86

29.87

29.87

 

 

TOTAL

243,000

29.49

 

* Two-digit rounding after the decimal

               

The detailed reporting is available:

  • On Klépierre’s website www.klepierre.com in the section: Finance / Regulated disclosures;

     Or directly at the following URL: https://www.klepierre.com/content/uploads/2019/06/Déclaration-des-transactions-sur-actions-propres-réalisées-du-07_au_10_juin_2019.pdf

      

      

Attachment

logo_blue.jpg

Related content
20 Aug - 
Klépierre: Disclosure of trading in own shares from Aug..
13 Aug - 
DISCLOSURE OF TRADING IN OWN SHARES FROM AUGUST 7, 2019..
06 Aug - 
Klépierre Publishes Its First-Half 2019 Financial Repor..
Del

Post comment

Related debate

  • 1 week
  • 1 month
  • 1 Year
Ingen indlæg

#

EuroInvestor: In Focus
#

#

EuroInvestor: In Focus
#

#

EuroInvestor: In Focus
#

Most read news

  • 24 hours
  • 48 hours
  • 1 week
1
Avinger Prices $4.5 Million Underwritten Public Offering of Common Stock
2
MYGN Loss Alert: Hagens Berman Investigating Myriad Genetics (MYGN) For Possible Disclosure Violations
3
Bone Therapeutics SA to report half year 2019 results on 30 August 2019
4
Genmab Announces Approval of DARZALEX® (daratumumab) in Frontline Multiple Myeloma in Japan
5
Ambu A/S: Interim report for Q3 2018/19

Related stock quotes

Klepierre 27.42 -0.2% Stock price decreasing

Latest news


Copyright Berlingske Media 2019  Cookie- and Privacy policy  |  Cookies  |   General terms of trade  |   Terms of use and IP rights
Quote information is delivered by Morningstar.
Data is delayed 15-20 minutes according to the distribution agreements set by the different exchanges.
 
22 August 2019 11:05:09
(UTC+00:00) Dublin, Edinburgh, Lisbon, London
Version: LiveBranchBuild_20190819.1 - EUROWEB5 - 2019-08-22 12:05:09 - 2019-08-22 11:05:09 - 1000 - Website: OKAY